Revenue for the third quarter was $197,000, compared with revenue of $230,000 for the third quarter of 2007. Revenue in the third quarter of 2008 was primarily the result of expense reimbursement from a third party for the evaluation of the delivery of certain compounds using the AERx(R) delivery system.

Total operating expenses for the third quarter of 2008 were $4.8 million, compared wi...